Cargando…

Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study

INTRODUCTION: Reduction in bone mineral density (BMD) is a common side effect of androgen deprivation therapy (ADT). We aimed to examine the cross-sectional and longitudinal variation in BMD and associated bone markers in patients with nonmetastatic prostate cancer (PCa) managed with and without ADT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Alice, Karunasinghe, Nishi, Plank, Lindsay, Zhu, Shuotun, Osborne, Sue, Bishop, Karen, Brown, Charis, Schwass, Tiffany, Masters, Jonathan, Holmes, Michael, Huang, Roger, Keven, Christine, Ferguson, Lynnette, Lawrenson, Ross
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638161/ https://www.ncbi.nlm.nih.gov/pubmed/29051709 http://dx.doi.org/10.1177/1179554917733449

Ejemplares similares

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
por: Wang, Alice, et al.
Publicado: (2021)

Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand
por: Wang, Alice, et al.
Publicado: (2015)

Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
por: Karunasinghe, Nishi, et al.
Publicado: (2016)

Selenium Supplementation and Prostate Health in a New Zealand Cohort
por: Karunasinghe, Nishi, et al.
Publicado: (2019)

Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts
por: Karunasinghe, Nishi, et al.
Publicado: (2018)

Benefits of Selenium Supplementation on Leukocyte DNA Integrity Interact with Dietary Micronutrients: A Short Communication
por: Karunasinghe, Nishi, et al.
Publicado: (2016)

Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand
por: Karunasinghe, Nishi, et al.
Publicado: (2019)

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
por: Lawrenson, Ross, et al.
Publicado: (2014)

An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer
por: Bishop, Karen S., et al.
Publicado: (2016)

A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet
por: Erdrich, Sharon, et al.
Publicado: (2015)

An Investigation into the Association between DNA Damage and Dietary Fatty Acid in Men with Prostate Cancer
por: Bishop, Karen S., et al.
Publicado: (2015)

Nutrigenetics, Nutrigenomics, and Selenium
por: Ferguson, Lynnette R., et al.
Publicado: (2011)

Selenium, Selenoprotein Genes and Crohn’s Disease in a Case-Control Population from Auckland, New Zealand
por: Gentschew, Liljana, et al.
Publicado: (2012)

Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions
por: Karunasinghe, Nishi, et al.
Publicado: (2022)

Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients
por: Marlow, Gareth, et al.
Publicado: (2013)

Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APC(MIN) Mouse Model
por: Asadi, Khalid, et al.
Publicado: (2017)

Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand
por: Obertová, Zuzana, et al.
Publicado: (2014)

Urban Rural Differences in Breast Cancer in New Zealand
por: Lawrenson, Ross, et al.
Publicado: (2016)

Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2011)

Effect of androgen deprivation therapy on bone mineral density in patients with prostate cancer
por: Ilyas, Kashaf, et al.
Publicado: (2022)

SNP-SNP interactions as risk factors for aggressive prostate cancer
por: Vaidyanathan, Venkatesh, et al.
Publicado: (2017)

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy
por: Neubecker, Katherine, et al.
Publicado: (2011)

Nutrigenomics and Nutrigenetics Research in New Zealand, and Its Relevance and Application to Gastrointestinal Health
por: Ferguson, Lynnette, et al.
Publicado: (2022)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Prostate Cancer: Is It a Battle Lost to Age?
por: Vaidyanathan, Venkatesh, et al.
Publicado: (2016)

Trends in deprivation in hospitalisations of Indigenous children and young people in Aotearoa New Zealand
por: Oben, Glenda, et al.
Publicado: (2022)

Zinc in Prostate Health and Disease: A Mini Review
por: Karunasinghe, Nishi
Publicado: (2022)

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
por: Neubecker, Katherine, et al.
Publicado: (2017)

The New Zealand Indices of Multiple Deprivation (IMD): A new suite of indicators for social and health research in Aotearoa, New Zealand
por: Exeter, Daniel John, et al.
Publicado: (2017)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Correction: Vaidyanathan et al. Are We Eating Our Way to Prostate Cancer—A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150. Non-Coding RNA 2016, 2, 2.
por: Vaidyanathan, Venkatesh, et al.
Publicado: (2016)

Are We Eating Our Way to Prostate Cancer—A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150
por: Vaidyanathan, Venkatesh, et al.
Publicado: (2016)

Mortality outcomes and inequities experienced by rural Māori in Aotearoa New Zealand
por: Crengle, Sue, et al.
Publicado: (2022)

Metallothionein genes: no association with Crohn's disease in a New Zealand population
por: Morgan, Angharad R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_af23ooejdlrh969tqp7i39due3